Difficulties in managing the surgical patient who is morbidly obese

Critical Care Medicine

Volumn 38, Issue SUPPL. 9, 2010, Pages

  King, David R ^a   Velmahos, George C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Morbid obesity; obese; overweight; pickwickian; volume of distribution

Indexed keywords

ENOXAPARIN; HYPNOTIC SEDATIVE AGENT;

ANTICOAGULATION; ARTIFICIAL VENTILATION; BODY MASS; BODY WEIGHT; CRITICAL ILLNESS; DEEP VEIN THROMBOSIS; DRUG DOSE COMPARISON; HEART FAILURE; HUMAN; INTENSIVE CARE; INVASIVE PROCEDURE; LUNG EMBOLISM; NUTRITIONAL SUPPORT; OBESITY; PATIENT MONITORING; PEER REVIEW; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; SEDATION; SURGICAL INFECTION; SURGICAL PATIENT; VENOUS THROMBOEMBOLISM; WEIGHT REDUCTION; WOUND HEALING IMPAIRMENT; MORBID OBESITY; ORGANIZATION AND MANAGEMENT; PHYSIOLOGIC MONITORING; PROCEDURES; SURGERY;

HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; MONITORING, PHYSIOLOGIC; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOEMBOLISM;

EID: 77956205764     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181ec54f6     Document Type: Article

References (86)

1. Vargo JJ: Procedural sedation and obesity: Waters left uncharted. Gastrointest Endosc 2009; 70:980-984
2. Welliver M, Bednarzyk M: Sedation considerations for the nonintubated obese patient in critical care. Crit Care Nurs Clin North Am 2009; 21:341-352, vi
3. Pelosi P, Croci M, Ravagnan I, et al: Respiratory system mechanics in sedated, paralyzed, morbidly obese patients. J Appl Physiol 1997; 82:811-818
4. McCallister JW, Adkins EJ, O'Brien JM Jr: Obesity and acute lung injury. Clin Chest Med 2009; 30:495-508, viii
5. Dossett LA, Heffernan D, Lightfoot M, et al: Obesity and pulmonary complications in critically injured adults. Chest 2008; 134: 974-980
6. Garrouste-Orgeas M, Troché G, Azoulay E, et al: Body mass index. An additional prognostic factor in ICU patients. Intensive Care Med 2004; 30:437-443
7. Akinnusi M, Pineda L, El Solh A: Effect of obesity on intensive care morbidity and mortality: A meta-analysis. Crit Care Med 2008; 36:151-158
8. Oliveros H, Villamor E: Obesity and mortality in critically ill adults: A systematic review and meta-analysis. Obesity 2008; 16:515-521
9. Hogue CW Jr, Stearns JD, Colantuoni E, et al: The impact of obesity on outcomes after critical illness: A meta-analysis. Intensive Care Med 2009; 35:1152-1170
10. La Colla L, Albertin A, La Colla G, et al: No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients. Eur J Anaesthesiol 2009; 26:362-369
11. Albertin A, Poli D, La Colla L, et al: Predictive performance of "Servin's formula" during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patients. Br J Anaesth 2007; 98:66-75
12. Bakhamees HS, El-Halafawy YM, El-Kerdawy HM, et al: Effects of dexmedetomidine in morbidly obese patients undergoing laparo-scopic gastric bypass. Middle East J Anesthe-siol 2007; 19:537-551
13. Ebert TJ, Shankar H, Haake RM: Periopera-tive considerations for patients with morbid obesity. Anesthesiol Clin 2006; 24:621-636
14. Cillo JE Jr, Finn R: Correlation and comparison of body mass index on hemodynamics in hypertensive and normotensive patients undergoing intravenous sedation. J Oral Max-illofac Surg 2006; 64:583-588
15. Leykin Y, Pellis T, Lucca M, et al: The phar-macodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 2004; 99:1086-1089
16. Graves DA, Batenhorst RL, Bennett RL, et al: Morphine requirements using patient-controlled analgesia: Influence of diurnal variation and morbid obesity. Clin Pharm 1983; 2:49-53
17. Hagle ME, Lehr VT, Brubakken K, et al: Respiratory depression in adult patients with intravenous patient-controlled analgesia. Orthop Nurs 2004; 23:18-27
18. Iyriboz Y, Hearon CM, Edwards K: Agreement between large and small cuffs in sphyg-momanometry: A quantitative assessment. J Clin Monit 1994; 10:127-133
19. Bur A, Hirschl MM, Herkner H, et al: Accuracy of oscillometric blood pressure measurement according to the relation between cuff size and upper-arm circumference in critically ill patients. Crit Care Med 2000; 28:371-376
20. Fonseca-Reyes S, de Alba-García JG, Parra-Carrillo JZ, et al: Effect of standard cuff on blood pressure readings in patients with obese arms How frequent are arms of a "large circumference"? Blood Press Monit 2003; 8:101-106
21. Manning DM, Kuchirka C, Kaminski J: Mis-cuffing: Inappropriate blood pressure cuff application. Circulation 1983; 68:763-766
22. Dahl OE: Mechanisms of hypercoagulability. Thromb Haemost 1999; 82:902-906
23. Carmody BJ, Sugerman HJ, Kellum JM, et al: Pulmonary embolism complicating bariatric surgery: Detailed analysis of a single institution's 24-year experience. J Am Coll Surg 2006; 203:831-837
24. Kim V, Spandorfer J: Epidemiology of venous thromboembolic disease. Emerg Med Clin North Am 2001; 19:839-859
25. Blaszyk H, Wollan PC, Witkiewicz AK, et al: Death from pulmonary thromboembolism in severe obesity: Lack of association with established genetic and clinical risk factors. Virchows Arch 1999; 434:529-532
26. Blaszyk H, Bjö rnsson J: Factor V leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg 2000; 135: 1410-1413
27. Prystowsky JB, Morasch MD, Eskandari MK, et al: Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery 2005; 138:759-765
28. Frederiksen SG, Hedenbro JL, Norgren L: Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients. Br J Surg 2003; 90:547-548
29. Bazinet A, Almanric K, Brunet C, et al: Dosage of enoxaparin among obese and renal impairment patients. Thromb Res 2005; 116:41-50
30. Scholten DJ, Hoedema RM, Scholten SE: A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002; 12:19-24
31. Simone EP, Madan AK, Tichansky DS, et al: Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery. Surg Endosc 2008; 22:2392-2395
32. Hamad GG, Choban PS: Enoxaparin for throm-boprophylaxis in morbidly obese patients undergoing bariatric surgery: Findings of the prophylaxis against vte outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg 2005; 15:1368-1374
33. Hirsh J, Bauer KA, Donati MB, et al: Paren-teral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 Suppl):141S-159S
34. Miller MT, Rovito PF: An approach to venous thromboembolism prophylaxis in laparo-scopic Roux-en-Y gastric bypass surgery. Obes Surg 2004; 14:731-737
35. Ferrell A, Byrne TK, Robison JG: Placement of inferior vena cava filters in bariatric surgical patients\Possible indications and technical considerations. Obes Surg 2004; 14:738-743
36. Piano G, Ketteler ER, Prachand V, et al: Safety, feasibility, and outcome of retrievable vena cava filters in high-risk surgical patients. J Vasc Surg 2007; 45:784-788
37. Vaziri K, Bhanot P, Hungness ES, et al: Retrievable inferior vena cava filters in high-risk patients undergoing bariatric surgery. Surg Endosc 2009; 23:2203-2207
38. Sapala JA, Wood MH, Schuhknecht MP, et al: Fatal pulmonary embolism after bariatric operations for morbid obesity: A 24-year retrospective analysis. Obes Surg 2003; 13:819-825
39. Kardys CM, Stoner MC, Manwaring ML, et al: The use of intravascular ultrasound imaging to improve use of inferior vena cava filters in a high-risk bariatric population. J Vasc Surg 2007; 46:1248-1252
40. Schuster R, Hagedorn JC, Curet MJ, et al: Retrievable inferior vena cava filters may be safely applied in gastric bypass surgery. Surg Endosc 2007; 21:2277-2279
41. Halmi D, Kolesnikov E: Preoperative placement of retrievable inferior vena cava filters in bariatric surgery. Surg Obes Relat Dis 2007; 3:602-605
42. Overby DW, Kohn GP, Cahan MA, et al: Risk-group targeted inferior vena cava filter placement in gastric bypass patients. Obes Surg 2009; 19:451-455
43. Sugerman HJ, Kellum JM, Engle KM, et al: Gastric bypass for treating severe obesity. Am J Clin Nutr 1992; 55(Suppl):560S-566S
44. Podnos YD, Jimenez JC, Wilson SE, et al: Complications after laparoscopic gastric bypass. Arch Surg 2003; 138:957-961
45. Sugerman HJ, Sugerman EL, Wolfe L, et al: Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg 2001; 234:41-46
46. Sugerman JF, Baron PL, Fairman RP, et al: Hemodynamic dysfunction in obesity hy-poventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg 1988; 207:604-613
47. Gargiulo NJ, Veith FJ, Lipsitz EC, et al: Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg 2006; 44:1301-1305
48. Keeling BW, Haines K, Stone PA, et al: Current indications for preoperative inferior vena cava filter insertion in patients undergoing surgery for morbid obesity. Obes Surg 2005; 15:1009-1012
49. Decousus H, Leizorovicz A, Parent F, et al: A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Préven-tion du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338:409-415
50. Snyder JM, Arita A, Inampudi C, et al: Intra-operative ultrasound guidance of vena caval umbrella placement in a super obese patient. Obes Surg 2002; 12:679-681
51. Michota FA: Prevention of venous thrombo-embolism after surgery. Cleve Clin J Med 2009; 76(Suppl 4):S45-S52
52. Nguyen NT, Cronan M, Braley S, et al: Duplex ultrasound assessment of femoral venous flow during laparoscopic and open gastric bypass. Surg Endosc 2003; 17:285-290
53. Kakkos SK, Caprini JA, Geroulakos G, et al: Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 2008; 8:CD005258
54. Kumpf VJ, Slocum K, Binkley J, et al: Complications after bariatric surgery: Survey evaluating impact on the practice of specialized nutrition support. Nutr Clin Pract 2007; 22: 673-678
55. Lynch RJ, Ranney DN, Shijie C, et al: Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009; 250:1014-1020
56. Itani KM, Jensen EH, Finn TS, et al: Effect of body mass index and ertapenem versus ce-fotetan prophylaxis on surgical site infection in elective colorectal surgery. Surg Infect (Larchmt) 2008; 9:131-137
57. Fleischmann E, Kurz A, Niedermayr M, et al: Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes Surg 2005; 15:813-819
58. Choban PS, Heckler R, Burge JC, et al: Increased incidence of nosocomial infections in obese surgical patients. Am Surg 1995; 61: 1001-1005
59. Forse RA, Karam B, MacLean LD, et al: Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106:750-756
60. Bamgbade OA, Rutter TW, Nafiu OO, et al: Postoperative complications in obese and nonobese patients. World J Surg 2007; 31: 556-560
61. Kirkland KB, Briggs JP, Trivette SL, et al: The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725-730
62. Cruse PJE, Foord R: The epidemiology of wound infection: A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980; 60:27-40
63. Lizán-Garcia M, García Caballero J, Asencio-Vegas A: Risk factors for surgical-wound infection in general surgery: A prospective study. Infect Control Hosp Epidemiol 1997; 18: 310-315
64. Babior BM: Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med 1978; 298:721-725
65. Bearden DT, Rodvold KA: Dosage adjustments for antibacterials in obese patients: Applying clinical pharmacokinetics. Clin Pharmacokinet 2000; 38:415-426
66. Bauer LA, Black DJ, Lill JS: Vancomycin dosing in morbidly obese patients. Eur J Clin Pharmacol 1998; 54:621-625
67. Classen DC, Evans RS, Pestotnik SL, et al: The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326:281-286
68. Chiba K, Tsuchiya M, Kato J, et al: Cefoteiam disposition in markedly obese athlete patients, Japanese sumo wrestlers. Antimicrobial Agents Chemother 1989; 33:1188-1190
69. Forse RA, Karam B, MacLean LD, et al: Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106:750-755
70. Mann HJ, Buchwald H: Cefamandole distribution in serum, adipose tissue, and wound drainage in morbidly obese patients. Drug Intell Clin Pharm 1986; 20:869-871
71. Barbour A, Schmidt S, Rout WR, et al: Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents 2009; 34:231-235
72. Pai MP, Bearden DT: Antimicrobial dosing considerations in obese adult patients. Phar-macotherapy 2007; 27:1081
73. Cutts ME, Dowdy RP, Ellersieck MR, et al: Predicting energy needs in ventilator-dependent critically ill patients: Effect of adjusting weight for edema or adiposity. Am J Clin Nutr 1997; 66:1250-1256
74. Ireton-Jones C: Adjusted body weight, con: why adjust body weight in energy-expenditure calculations? Nutr Clin Pract 2005; 20:474-479
75. Elamin EM: Nutritional care of the obese intensive care unit patient. Curr Opin Crit Care 2005; 11:300-303
76. Port AM, Apovian C: Metabolic support of the obese intensive care unit patient: A current perspective. Curr Opin Clin Nutr Metab Care 2010; 13:184-191
77. Honiden S, McArdle JR: Obesity in the intensive care unit. Clin Chest Med 2009; 30: 581-599, x
78. Reeds DN: Nutrition support in the obese, diabetic patient: The role of hypocaloric feeding. Curr Opin Gastroenterol 2009; 25:151-154
79. Dickerson RN, Boschert KJ, Kudsk KA, et al: Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition 2002; 18:241-246
80. Watcha MF, White PF: Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77:162-184
81. Morino M, Toppino M, Forestieri P, et al: Mortality after bariatric surgery: Analysis of 13,871 morbidly obese patients from a national registry. Ann Surg 2007; 246:1002-1007
82. Gugliotti D, Grant P, Jaber W, et al: Challenges in cardiac risk assessment in bariatric surgery patients. Obes Surg 2008; 18:129-133
83. van den Broek RJ, Buise MP, van Dielen FM, et al: Characteristics and outcome of patients admitted to the ICU following bariatric surgery. Obes Surg 2009; 19:560-564
84. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al: Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361:445-454
85. Gallagher MJ, Franklin BA, Ehrman JK, et al: Comparative impact of morbid obesity vs heart failure on cardiorespiratory fitness. Chest 2005; 127:2197-2203
86. Arnlöv J, Ingelsson E, Sundström J, et al: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121:230-236